NICM
FOLD

Neo Ivy Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Neo Ivy Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.69M Sell
186,172
-234,103
-56% -$3.36M 0.71% 39
2025
Q4 		$5.98M Buy
420,275
+371,011
+753% +$3.64M 0.95% 27
2025
Q3 		$388K Buy
+49,264
New +$351K 0.09% 263
2025
Q1 		– Sell
-395,745
Closed -$3.73M – 333
2024
Q4 		$3.73M Buy
395,745
+329,959
+502% +$3.43M 0.75% 27
2024
Q3 		$702K Buy
+65,786
New +$716K 0.23% 172
2023
Q4 		– Sell
-6,244
Closed -$76K – 349
2023
Q3 		$76K Sell
6,244
-21,074
-77% -$272K 0.03% 265
2023
Q2 		$343K Buy
+27,318
New +$324K 0.18% 185
2022
Q4 		$121K Buy
+9,882
New +$111K 0.08% 254
2022
Q2 		– Sell
-3,318
Closed -$32K – 481
2022
Q1 		$32K Buy
3,318
+1,864
+128% +$17.5K 0.03% 401
2021
Q4 		$17K Sell
1,454
-1,618
-53% -$18K 0.02% 366
2021
Q3 		$46K Sell
3,072
-33,522
-92% -$343K 0.05% 330
2021
Q2 		$353K Buy
+36,594
New +$357K 0.36% 108
2021
Q1 		– Sell
-6,178
Closed -$143K – 523
2020
Q4 		$143K Buy
6,178
+3,202
+108% +$65.5K 0.16% 203
2020
Q3 		$42K Sell
2,976
-96
-3% -$1.4K 0.04% 376
2020
Q2 		$46K Sell
3,072
-12,423
-80% -$151K 0.05% 330
2020
Q1 		$143K Buy
15,495
+4,147
+37% +$39.4K 0.23% 174
2019
Q4 		$111K Buy
+11,348
New +$104K 0.13% 186
2019
Q3 		– Sell
-4,448
Closed -$56K – 324
2019
Q2 		$56K Buy
4,448
+252
+6% +$3.2K 0.03% 230
2019
Q1 		$57K Buy
+4,196
New +$51.3K 0.03% 249

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Neo Ivy Capital Management's FOLD Position: Q1 2026 in Review

Neo Ivy Capital Management reduced its Amicus Therapeutics (FOLD) stake by 56% in Q1 2026, selling an estimated $3.36M and leaving 186,172 shares worth $2.69M. The position accounts for 0.71% of the portfolio, ranked #39.

Neo Ivy Capital Management first reported a position in FOLD in Q1 2019 and has held it in 19 quarters since. The position peaked at $5.98M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Neo Ivy Capital Management held 186,172 shares of Amicus Therapeutics worth $2.69M as of Q1 2026.
  • Neo Ivy Capital Management sold 234,103 Amicus Therapeutics shares in Q1 2026, an estimated $3.36M.
  • Amicus Therapeutics made up 0.71% of Neo Ivy Capital Management's portfolio in Q1 2026, its #39 holding.
  • Neo Ivy Capital Management first reported a position in Amicus Therapeutics in Q1 2019 and has held it in 19 quarters since.
  • Neo Ivy Capital Management's Amicus Therapeutics position peaked at $5.98M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.